These Analysts Revise Price Targets On Signify Health Following Acquisition News

CVS Health Corp CVS agreed to acquire Signify Health Inc SGFY for $30.50 per share in cash, representing a total transaction value of approximately $8 billion.

Signify Health shares gained 0.2% to $28.83 on Tuesday.

Several analysts made changes to their price targets on Signify Health today.

  • Baird boosted the price target on the stock from $28 to $30.5. Baird analyst Vikram Kesavabhotla downgraded the stock from Outperform to Neutral.
  • RBC Capital increased price target on the stock from $20 to $30.5. RBC Capital analyst Sean Dodge maintained Signify Health with a Sector Perform.
  • JP Morgan, however, lowered the price target on the stock from $32 to $30.5. JP Morgan analyst Anne Samuel downgraded the stock from Overweight to Neutral.
  • Piper Sandler also cut the price target on the stock from $34 to $30.5. Piper Sandler analyst Jessica Tassan downgraded the stock from Overweight to Neutral.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: M&ANewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading IdeasPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!